List of Studies ( Metabolite:NAD)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST003252 | AN005328 | Metabolomics studies on mouse cardiac samples on a Western diet | Heart | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
ST003252 | AN005329 | Metabolomics studies on mouse cardiac samples on a Western diet | Heart | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
ST003253 | AN005331 | Metabolomics studies on mouse liver samples on a Western diet | Liver | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
ST003253 | AN005332 | Metabolomics studies on mouse liver samples on a Western diet | Liver | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
ST003438 | AN005651 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fly | Parkinson's Disease | Broad Institute of MIT and Harvard | Abundances |
ST003199 | AN005249 | Metabolite profiling in the liver from fasted eIF4ES209A (S209A) mice compared to fasted wild type (WT) mice | Liver | Mouse | Cancer | University of Chicago | A.U. |
ST003365 | AN005514 | Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003365 | AN005515 | Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003366 | AN005516 | Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro | Synthetic | Other | Cancer | Wistar Institute | Counts per second (cps) |
ST003366 | AN005517 | Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro | Synthetic | Other | Cancer | Wistar Institute | Counts per second (cps) |
ST003367 | AN005518 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003367 | AN005519 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003411 | AN005602 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003411 | AN005603 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003412 | AN005604 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003412 | AN005605 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003427 | AN005627 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Breast cancer cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003427 | AN005628 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Breast cancer cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003428 | AN005629 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003428 | AN005630 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003429 | AN005631 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003429 | AN005632 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003430 | AN005633 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003430 | AN005634 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003431 | AN005635 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003431 | AN005636 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003432 | AN005637 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003432 | AN005638 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003433 | AN005639 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003433 | AN005640 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003434 | AN005641 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003434 | AN005642 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Human | Cancer | Wistar Institute | Counts per second (cps) |
ST003435 | AN005643 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media, Metabolite extract | Zebra fish | Cancer | Wistar Institute | Counts per second (cps) |
ST003435 | AN005644 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media, Metabolite extract | Zebra fish | Cancer | Wistar Institute | Counts per second (cps) |
ST003436 | AN005645 | Pharmacokinetics of Fasnall in NSG mice | Brain, Heart, Liver, Blood | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Brain, Heart, Liver, Blood | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
ST003323 | AN005439 | Global Metabolomics and U-13C6-Glucose Tracing in Bone Marrow Derived Macrophages (BMDM) | Bone marrow | Mouse | Immune system disorders | University of Colorado Anschutz Medical Campus | Intensity Counts |
ST003549 | AN005833 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Blood, Tissue | Mouse | Metabolic Disorders | University of British Columbia | Ion counts |
ST003549 | AN005834 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Blood, Tissue | Mouse | Metabolic Disorders | University of British Columbia | Ion counts |
ST003551 | AN005837 | Metabolomics analysis of N-methyl-arginine-treated HEK293 control (sgTomato) and ALDH7A1-deficient (sgALDH7A1) cells. | Cultured cells | Human | University of British Columbia | Ion counts | |
ST003551 | AN005838 | Metabolomics analysis of N-methyl-arginine-treated HEK293 control (sgTomato) and ALDH7A1-deficient (sgALDH7A1) cells. | Cultured cells | Human | University of British Columbia | Ion counts | |
ST003454 | AN005675 | Branched chain alpha-ketoacids impact pulmonary artery smooth muscle cell metabolism | Cultured cells | Human | Hypertension | Peking University | ion intensity |
ST003455 | AN005676 | Metabolic alterations in pulmonary artery smooth muscle cells of idiopathic pulmonary arterial hypertension (IPAH) patients. | Cultured cells | Human | Hypertension | Peking University | ion intensity |
ST003405 | AN005588 | Specific activation of the integrated stress response uncovers regulation of central carbon metabolism and lipid droplet biogenesis | Cultured cells | Human | Cancer | Calico Life Sciences | log2 peak area top |
ST003405 | AN005589 | Specific activation of the integrated stress response uncovers regulation of central carbon metabolism and lipid droplet biogenesis | Cultured cells | Human | Cancer | Calico Life Sciences | log2 peak area top |
ST003331 | AN005457 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular metabolomics | Stem cells | Human | Multiple sclerosis | University of Colorado Denver | peak area |
ST003347 | AN005482 | ADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation | Skin | Human | Neuropathy | Catholic University of the Sacred Heart | peak area |
ST003484 | AN005722 | Metabolism of TNBC cell line MDA-MB-453 is altered by cytokines, TDO2 inhibition, or suspension growth conditions - cellular steady state metabolome and in vitro tracing with 13C11 tryptophan | Tumor cells | Human | Cancer | University of Colorado Anschutz Medical Campus | peak area |
ST003499 | AN005743 | Metabolic analysis of ADSL deficiency patients' EBV-LCLs. | Blood | Human | Mitochondrial Dysfunction | Catholic University of the Sacred Heart | peak area |
ST003499 | AN005744 | Metabolic analysis of ADSL deficiency patients' EBV-LCLs. | Blood | Human | Mitochondrial Dysfunction | Catholic University of the Sacred Heart | peak area |
ST003249 | AN005322 | Mitochondrial respiration impairment in microglia dampens response to demyelinating injury but is not sufficient to induce an aging phenotype | Microglia | Mouse | Alzheimers disease | Northwestern University | Peak area |
ST003265 | AN005349 | Malic Enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells | T-cells | Mouse | Cancer | Peking Union Medical College | Peak area |
ST003577 | AN005873 | Multi ‘omics indicate depth-discrete partitioning of nitrogen metabolism in a toxic Planktothrix rubescens bloom in the winter water column | Water | Other | University of Tennessee | Peak area | |
ST003340 | AN005474 | Effect of feeding and the mTORC1 activity on metabolism in Caenorhabditis elegans | Worm | Roundworm | Hiroshima University | peak areas | |
ST003521 | AN005782 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | peak height |
ST003521 | AN005783 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | peak height |
ST003313 | AN005425 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - feces | Feces | Human | Inflammatory bowel disease; Crohn disease | Sheba hospital | percentage of metabolites per sample |
ST003495 | AN005735 | Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock | Liver | Mouse | Washington University in St. Louis | Raw Area | |
ST003389 | AN005558 | Disruption of Glucose Homeostasis by Bacterial Infection Orchestrates Host Innate Immunity Through NAD+/NADH Balance | Macrophage | Mouse | Bacterial infection | Northwest A&F University | umol/g |
ST003389 | AN005557 | Disruption of Glucose Homeostasis by Bacterial Infection Orchestrates Host Innate Immunity Through NAD+/NADH Balance | Macrophage | Mouse | Bacterial infection | Northwest A&F University | μmol/g |
ST003267 | AN005353 | FDX2-KO induces global down-regulation of iron-sulfur cluster-containing proteins and senescence-like growth arrest or death in ovarian cancer cells | Cultured cells | Human | Cancer | Tohoku University | μmol/g-protein |